| abstract |
This invention relates to novel quinazolines, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an inhibitor of angiogenesis and vascular endothelial growth factor receptor (VEGF) kinases. |